Ferric carboxymaltose: a review of its use in iron-deficiency anaemia.

Editorial: Drugs
Fecha: 01/07/2009
Lyseng-Williamson KA, Keating GM.

Ferric carboxymaltose (Ferinject(R)), a novel iron complex that consists of a ferric hydroxide core stabilized by a carbohydrate shell, allows for controlled delivery of iron to target tissues. Administered intravenously, it is effective in the treatment of iron-deficiency anaemia, delivering a replenishment dose of up to 1000 mg of iron during a minimum administration time of

Deja una respuesta